The cyclooxygenase 2 -765 C promoter allele is a protective factor for Alzheimer's disease
Authors:
- Laila AbdullahLALaila Abdullah
- Ghania Ait-GhezalaGAGhania Ait-Ghezala
- Fiona CrawfordFCFiona Crawford
- Timothy A. CrowellTCTimothy A. Crowell
- Warren W. BarkerWBWarren W. Barker
- Ranjan DuaraRDRanjan Duara
- Michael MullanMMMichael Mullan
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 395 (3) , 240-243
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- PTGS2 (COX-2) −765G > C Promoter Variant Reduces Risk of Colorectal Adenoma among Nonusers of Nonsteroidal Anti-inflammatory DrugsCancer Epidemiology, Biomarkers & Prevention, 2005
- The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysis*Current Medical Research and Opinion, 2004
- Common Promoter Variant in Cyclooxygenase-2 Represses Gene ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's diseaseJournal of Neuroscience Research, 1999
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- A Randomized, Double-Blind, Crossover Comparative Endoscopy Study on the Gastroduodenal Tolerability of a Highly Specific Cyclooxygenase-2 Inhibitor, Flosulide, and NaproxenScandinavian Journal of Gastroenterology, 1997
- THE ROLE OF CYCLOOXYGENASE-2 IN INFLAMMATIONAmerican Journal of Therapeutics, 1995
- Assignment of the Human Prostaglandin-Endoperoxide Synthase 2 (PTGS2) Gene to 1q25 by Fluorescence in Situ HybridizationGenomics, 1994
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984